Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Operating Leases (2019 - 2025)

Historic Operating Leases for Nephros (NEPH) over the last 7 years, with Q3 2025 value amounting to $774000.0.

  • Nephros' Operating Leases fell 3292.89% to $774000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $774000.0, marking a year-over-year decrease of 3292.89%. This contributed to the annual value of $1.1 million for FY2024, which is 2352.52% down from last year.
  • Per Nephros' latest filing, its Operating Leases stood at $774000.0 for Q3 2025, which was down 3292.89% from $872000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' Operating Leases ranged from a high of $1.4 million in Q4 2023 and a low of $201000.0 during Q3 2022
  • Over the past 5 years, Nephros' median Operating Leases value was $739500.0 (recorded in 2022), while the average stood at $770437.5.
  • Its Operating Leases has fluctuated over the past 5 years, first plummeted by 5520.42% in 2021, then surged by 14605.54% in 2024.
  • Quarter analysis of 5 years shows Nephros' Operating Leases stood at $340000.0 in 2021, then skyrocketed by 107.35% to $705000.0 in 2022, then skyrocketed by 97.16% to $1.4 million in 2023, then fell by 23.53% to $1.1 million in 2024, then dropped by 27.19% to $774000.0 in 2025.
  • Its last three reported values are $774000.0 in Q3 2025, $872000.0 for Q2 2025, and $969000.0 during Q1 2025.